Literature DB >> 28500921

Development and validation of two measures of emotional contrast avoidance: The contrast avoidance questionnaires.

Sandra J Llera1, Michelle G Newman2.   

Abstract

The Contrast Avoidance (CA) model (Newman & Llera, 2011) proposed that individuals with generalized anxiety disorder (GAD) fear sharp emotional shifts (or contrasts), such as the shift from a pleasant or neutral state to one of sudden distress following a negative event. Further, the model suggests that chronic worry is employed by those with GAD to sustain negative emotionality as a means to avoid sudden shifts into negativity. The model has received empirical support; however, no validated measure exists to assess CA tendencies. In this paper we developed and tested two measures of CA: one focusing on worry, and another examining broader mechanisms of CA that could be used test whether CA is applicable to other disorders. In Study 1, Part 1, we used 3 samples of participants (each N=410) to perform item reduction, exploratory factor analysis, and confirmatory factor analysis. In Study 1, Part 2, we performed tests of construct validity. In Study 2, we used a new sample (N=126) to determine test-retest reliability. All data point to the strong psychometric properties of the CA questionnaires and their relationship to GAD. Both measures distinguished between participants reporting clinical levels of GAD symptoms and nonanxious controls, demonstrating their utility as complementary measures of CA tendencies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Assessment; Confirmatory factor analysis; Contrast avoidance model; Emotion dysregulation; Generalized anxiety disorder

Mesh:

Year:  2017        PMID: 28500921      PMCID: PMC8765496          DOI: 10.1016/j.janxdis.2017.04.008

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  41 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

2.  Perceived functions of worry among generalized anxiety disorder subjects: distraction from more emotionally distressing topics?

Authors:  T D Borkovec; L Roemer
Journal:  J Behav Ther Exp Psychiatry       Date:  1995-03

3.  Physiological and neural correlates of worry and rumination: Support for the contrast avoidance model of worry.

Authors:  Elisa C K Steinfurth; Manuela G Alius; Julia Wendt; Alfons O Hamm
Journal:  Psychophysiology       Date:  2016-10-21       Impact factor: 4.016

4.  Relaxation-induced anxiety in a subclinical sample of chronically anxious subjects.

Authors:  J A Braith; J P McCullough; J P Bush
Journal:  J Behav Ther Exp Psychiatry       Date:  1988-09

5.  Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder.

Authors:  Amit Etkin; Katherine E Prater; Fumiko Hoeft; Vinod Menon; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2010-02-01       Impact factor: 18.112

6.  Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.

Authors:  Carmen Andreescu; Lei K Sheu; Dana Tudorascu; James J Gross; Sarah Walker; Layla Banihashemi; Howard Aizenstein
Journal:  Am J Geriatr Psychiatry       Date:  2014-05-17       Impact factor: 4.105

7.  Psychophysiological correlates of generalized anxiety disorder with or without comorbid depression.

Authors:  Stefan G Hofmann; Stefan M Schulz; Sanna Heering; Frederick Muench; Lynn F Bufka
Journal:  Int J Psychophysiol       Date:  2010-01-21       Impact factor: 2.997

8.  Perceived Emotion Control Moderates the Relationship between Neuroticism and Generalized Anxiety Disorder.

Authors:  Michelle L Bourgeois; Timothy A Brown
Journal:  Cognit Ther Res       Date:  2015-08

9.  Prospective Investigation of the Contrast Avoidance Model of Generalized Anxiety and Worry.

Authors:  Tara A Crouch; Jamie A Lewis; Thane M Erickson; Michelle G Newman
Journal:  Behav Ther       Date:  2016-10-29

10.  Specifically altered brain responses to threat in generalized anxiety disorder relative to social anxiety disorder and panic disorder.

Authors:  Christine Buff; Leonie Brinkmann; Paula Neumeister; Katharina Feldker; Carina Heitmann; Bettina Gathmann; Tanja Andor; Thomas Straube
Journal:  Neuroimage Clin       Date:  2016-10-05       Impact factor: 4.881

View more
  6 in total

1.  The impact of uncontrollability beliefs and thought-related distress on ecological momentary interventions for generalized anxiety disorder: A moderated mediation model.

Authors:  Lucas S LaFreniere; Michelle G Newman
Journal:  J Anxiety Disord       Date:  2019-07-13

2.  Probabilistic Learning by Positive and Negative Reinforcement in Generalized Anxiety Disorder.

Authors:  Lucas S LaFreniere; Michelle G Newman
Journal:  Clin Psychol Sci       Date:  2018-11-19

3.  The paradox of relaxation training: Relaxation induced anxiety and mediation effects of negative contrast sensitivity in generalized anxiety disorder and major depressive disorder.

Authors:  Hanjoo Kim; Michelle G Newman
Journal:  J Affect Disord       Date:  2019-08-19       Impact factor: 4.839

4.  Avoidance of negative emotional contrast from worry and rumination: An application of the Contrast Avoidance Model.

Authors:  Hanjoo Kim; Michelle G Newman
Journal:  J Behav Cogn Ther       Date:  2022-01-25

5.  Correlates of Dampening and Savoring in Generalized Anxiety Disorder.

Authors:  Bailee L Malivoire; Gabrielle Marcotte-Beaumier; David Sumantry; Naomi Koerner
Journal:  Int J Cogn Ther       Date:  2022-09-16

6.  Development of an Assessment Tool of Menstrual-Cycle-Related Signs and Symptoms Based on Thai Traditional Medicine Principles for Evaluation of Women's Health.

Authors:  Kodchanipha Sutthibut; Arunporn Itharat; Phechnoy Singchungchai; Preecha Wanichsetakul; Weerachai Pipatrattanaseree; Buncha Ooraikul; Neal M Davies
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-21       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.